Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ASND compared with CYTK: revenue, margins and what each company keeps, and the suppliers and customers both name
ASND
Ascendis Pharma A/S
Change
Mkt cap
Revenue
Revenue
CYTK
Cytokinetics Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
ASND
Ascendis Pharma A/S
vs
CYTK
Cytokinetics Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ASND, solid
CYTK, dashed
ASND
Ascendis Pharma A/S
Change
251.21
▲
+0.90%
Mkt cap
$15.6B
Revenue
—
Revenue
—
CYTK
Cytokinetics Inc
Change
63.09
▲
+1.71%
Regular session
Nov 3 '26
Mkt cap
$8.8B
Revenue
$29M
Q2 FY26
Revenue
$88M
FY25
vs
Compare
Regular session
Nov 3 '26
ASND
Ascendis Pharma A/S
vs
CYTK
Cytokinetics Inc
251.21
▲
+0.90%
Price
63.09
▲
+1.71%
$15.6B
Mkt cap
$8.8B
—
Revenue
$29M
Q2 FY26
—
Revenue
$88M
FY25
Change
Change
ASND
251.21
▲
+0.90%
vs
CYTK
63.09
▲
+1.71%
Regular session
Nov 3 '26